In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)
5 More presentations in this session
Doctor C. Fumagalli (Naples, IT)
Mr R. Huurman (Rotterdam, NL)
Mr G. Chatzantonis (Munster, DE)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
